Merck & Co in talks to buy Bangalore-based Micro Labs: report
21 June 2012
Merck & Co. Inc., the second largest drugmaker in the US is in talks to buy Bangalore-based active pharmaceutical ingredients maker Micro Labs Ltd., the Financial Express today reported, citing an unidentified sources.
Founded in 1985 by the Surana family, Micro Labs is a fully integrated pharmaceutical company, present across the entire pharmaceutical value chain from research and development, APIs, finished formulations to marketing and distribution.
Its portfolio of drugs are used in cardiology, diabetology, anti-infectives, ophthalmology and pain segment.
It has presence in more than 30 countries and has 3,300 product registrations in various stages. Its major markets are the Indian Subcontinent, East Europe, Central America, North Europe, South America, South/West Europe and North America.
The privately-run company aims to achieve $1 billion sales by 2015, according to its website.
In April, the company announced that it was in separate talks with GlaxoSmithKline and Teva Pharma.